351 related articles for article (PubMed ID: 15977774)
1. Efficacy of implantable cardioverter-defibrillators: from trials to the real world.
De Sousa J
Rev Port Cardiol; 2005 Apr; 24(4):501-4. PubMed ID: 15977774
[No Abstract] [Full Text] [Related]
2. The evolution and revolution of the implantable cardioverter defibrillator.
Indik JH
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
[No Abstract] [Full Text] [Related]
3. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.
Thakor NV; Natarajan A
Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992
[TBL] [Abstract][Full Text] [Related]
4. [Indication of implantable cardioverter defibrillator for heart failure].
Noda T; Kamakura S
Nihon Rinsho; 2007 May; 65 Suppl 5():195-9. PubMed ID: 17571384
[No Abstract] [Full Text] [Related]
5. Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy.
Choi GR; Porter CB; Ackerman MJ
Pediatr Clin North Am; 2004 Oct; 51(5):1289-303. PubMed ID: 15331285
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter defibrillators in children.
Chun TU; Collins KK; Dubin AM
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
[TBL] [Abstract][Full Text] [Related]
7. ICD therapy: what have we learned from the clinical trials?
Arya A; Haghjoo M; Sadr-Ameli MA
Heart Lung Circ; 2006 Feb; 15(1):3-11. PubMed ID: 16473784
[TBL] [Abstract][Full Text] [Related]
8. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
Moss AJ
Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
[No Abstract] [Full Text] [Related]
9. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
10. Implantation of cardioverter defibrillator in post-myocardial infarction patients: when and how?
Efthimiadis GK; Mezilis NE; Styliadis IH
Eur Heart J; 2007 Oct; 28(19):2416. PubMed ID: 17656348
[No Abstract] [Full Text] [Related]
11. Sudden death prevention with implantable devices.
Passman R; Kadish A
Circulation; 2007 Jul; 116(5):561-71. PubMed ID: 17664385
[No Abstract] [Full Text] [Related]
12. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].
Disertori M
G Ital Cardiol (Rome); 2011 May; 12(5):374-8; discussion 378. PubMed ID: 21593957
[No Abstract] [Full Text] [Related]
13. T-wave alternans in the sudden cardiac death in heart failure trial population: signal or noise?
Rosenbaum DS
Circulation; 2008 Nov; 118(20):2015-8. PubMed ID: 19001031
[No Abstract] [Full Text] [Related]
14. Shouldn't everyone have an implantable cardioverter-defibrillator?
Passman R; Kadish A
Circulation; 2009 Dec; 120(22):2166-7. PubMed ID: 19917881
[No Abstract] [Full Text] [Related]
15. [Implantable defibrillator. Update].
Maury P; Schläpfer J; Metzger J; Delacrétaz E; Fromer M; Kappenberger L
Rev Med Suisse Romande; 2001 Apr; 121(4):319-25. PubMed ID: 11400406
[TBL] [Abstract][Full Text] [Related]
16. Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children.
Boriani G; Biffi M; Valzania C; Bronzetti G; Martignani C
Eur Heart J; 2006 Oct; 27(20):2382-4. PubMed ID: 16952927
[No Abstract] [Full Text] [Related]
17. Patient selection for implantable cardioverter defibrillators.
Tanaka S
Ann Thorac Cardiovasc Surg; 1998 Jun; 4(3):107-9. PubMed ID: 9714591
[No Abstract] [Full Text] [Related]
18. Treating electrical instability in sudden cardiac death survivors -- are we looking at the right side of the coin?
Weber H; Allikmets K; Kornfeld G
Eur Heart J; 2004 Apr; 25(8):623-5. PubMed ID: 15084363
[No Abstract] [Full Text] [Related]
19. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
20. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
Siddiqui A; Kowey PR
Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
